Journal profile · MATERIALS SCIENCE, BIOMATERIALS
Progress in Biomaterials
ISSN 2194-0509 · eISSN 2194-0517 · Springer Nature · 4 issues per year
Progress in Biomaterials: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.24; fully open access; APC charged, amount not published; 24 articles a year; indexed in SCIE and Scopus.
The latest issue on the journal's website is from June 2023 (Volume 12, Issue 2): the journal may have stopped publishing or moved platform in the last two years. Check its website before submitting.
Scope
Aims, scope and focus
Progress in Biomaterials is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone Tissue Engineering Materials, Electrospun Nanofibers in Biomedical Applications and Advanced Drug Delivery Systems, together about 36.8% of its articles. Its main subfields are Biomaterials. (generated from OpenAlex topic counts and CAS ranking data)
Progress in Biomaterials is a multidisciplinary, English-language publication of original contributions and reviews concerning studies of the preparation, performance and evaluation of biomaterials; the chemical, physical, biological and mechanical behavior of materials both in vitro and in vivo in areas such as tissue engineering and regenerative medicine, drug delivery and implants where biomaterials play a significant role. Including all areas of: design; preparation; performance and evaluation of nano- and biomaterials in tissue engineering; drug delivery systems; regenerative medicine; implantable medical devices; interaction of cells/stem cells on biomaterials and related applications. As of 1st January 2025, the Progress in Biomaterials will be published with OICC Press, see: https://oiccpress.com/
From the journal's Aims & Scope
Research area (LetPub): MATERIALS SCIENCE, BIOMATERIALS
Editor-in-chief Hamid Mirzadeh DepartmentsPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone Tissue Engineering MaterialsEngineering15.4%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science14.7%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.7%
- Silk-based biomaterials and applicationsMaterials Science5.2%
- Tissue Engineering and Regenerative MedicineMedicine4.8%
- Nanoparticle-Based Drug DeliveryMaterials Science4.3%
- Orthopaedic implants and arthroplastyMedicine4%
- biodegradable polymer synthesis and propertiesMaterials Science4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
| Minor | Materials Science, Biomaterials | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
| Minor | Materials Science, Biomaterials | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.24LetPub ·
- CiteScore 2026-06
- 9.2LetPub ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 1.44LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 169OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 1.89%LetPub ·
Volume
- Articles per year
- 24LetPub ·
- Downloads per year (publisher) 2024
- 151,100Publisher website ·
Articles by year OpenAlex count · 216 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2023 | 6 | 6 | 134 |
| 2022 | 38 | 37 | 957 |
| 2021 | 27 | 27 | 658 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Editorial review, Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,090 | Yes | CC BY | |
| OpenAlex | USD 3,090 / EUR 2,490 / GBP 2,190 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Author–date
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Optional data availability statement Model summary
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
COPE member Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Articles in Springer Nature open access journals do not require transfer of copyright as the copyright remains with the author. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Progress in Biomaterials, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 2194-0509
- Electronic ISSN
- 2194-0517
- Latest issue on the website
- Volume 12, Issue 2 (June 2023)
- Official links
FAQ
Frequently asked questions about Progress in Biomaterials
What CAS zone is Progress in Biomaterials in?
In the 2025 upgraded edition of the CAS Journal Ranking, Progress in Biomaterials is in Zone 4 of Medicine, and in Zone 4 of the minor category Engineering, Biomedical / Materials Science, Biomaterials. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Progress in Biomaterials?
The latest impact factor listed by LetPub is 1.24; CiteScore 9.2, h-index 53.
What are the manuscript requirements of Progress in Biomaterials?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Author–date. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Progress in Biomaterials?
According to LetPub and DOAJ records, Progress in Biomaterials is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Progress in Biomaterials open access, and what is the APC?
Progress in Biomaterials is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .